ERYTECH Pharma announces the oral presentation of very demonstrative results regarding its technology to Induce specific immune tolerance by antigen loaded erythrocytes. Post author:admERY Post published:September 7, 2012 Post category:Newsroom You Might Also Like ERYTECH to Participate in the Citi 16th Annual BioPharma Conference August 30, 2021 ERYTECH Pharma signs licensing and distribution agreement with Orphan Europe for GRASPA® in Europe November 23, 2012 ERYTECH to Present at Morgan Stanley Global Healthcare Conference September 12, 2017
ERYTECH Pharma signs licensing and distribution agreement with Orphan Europe for GRASPA® in Europe November 23, 2012
